Russell Investments Group Ltd. Has $3.01 Million Stock Holdings in Rxo Inc $RXO

Russell Investments Group Ltd. lifted its stake in shares of Rxo Inc (NYSE:RXO) by 67.3% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 191,318 shares of the company’s stock after purchasing an additional 76,965 shares during the quarter. Russell Investments Group Ltd. owned 0.12% of RXO worth $3,008,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Intech Investment Management LLC grew its stake in RXO by 87.1% during the first quarter. Intech Investment Management LLC now owns 94,527 shares of the company’s stock worth $1,805,000 after buying an additional 44,001 shares in the last quarter. T. Rowe Price Investment Management Inc. acquired a new position in shares of RXO in the 1st quarter valued at approximately $56,693,000. Invesco Ltd. lifted its holdings in shares of RXO by 19.0% during the 1st quarter. Invesco Ltd. now owns 754,778 shares of the company’s stock worth $14,416,000 after acquiring an additional 120,275 shares during the period. Nuveen LLC bought a new stake in shares of RXO during the 1st quarter worth approximately $8,107,000. Finally, EFG Asset Management North America Corp. boosted its position in shares of RXO by 28.4% during the 2nd quarter. EFG Asset Management North America Corp. now owns 143,927 shares of the company’s stock worth $2,264,000 after acquiring an additional 31,860 shares in the last quarter. Institutional investors own 92.73% of the company’s stock.

Analyst Upgrades and Downgrades

RXO has been the subject of several research analyst reports. Susquehanna lowered their price objective on shares of RXO from $11.00 to $10.00 and set a “negative” rating for the company in a research report on Friday, November 7th. Stifel Nicolaus raised their target price on RXO from $14.00 to $17.00 and gave the company a “hold” rating in a report on Friday, October 10th. Barclays decreased their price target on RXO from $17.00 to $15.00 and set an “overweight” rating on the stock in a research note on Friday, November 7th. Wall Street Zen downgraded RXO from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Finally, Zacks Research cut RXO from a “hold” rating to a “strong sell” rating in a research report on Thursday, November 6th. Four analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $16.69.

Insider Activity at RXO

In other RXO news, Director Thomas A. Szlosek purchased 20,308 shares of the firm’s stock in a transaction on Friday, November 7th. The stock was purchased at an average cost of $12.37 per share, for a total transaction of $251,209.96. Following the transaction, the director owned 36,508 shares in the company, valued at $451,603.96. The trade was a 125.36% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Andrew M. Wilkerson purchased 7,775 shares of the business’s stock in a transaction dated Monday, November 10th. The shares were acquired at an average price of $12.88 per share, for a total transaction of $100,142.00. Following the acquisition, the chief executive officer owned 7,775 shares of the company’s stock, valued at $100,142. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired a total of 40,250 shares of company stock worth $488,875 in the last quarter. 1.48% of the stock is owned by insiders.

RXO Trading Down 2.0%

Shares of RXO stock opened at $14.14 on Tuesday. Rxo Inc has a twelve month low of $10.43 and a twelve month high of $29.60. The stock’s fifty day simple moving average is $15.03 and its 200 day simple moving average is $15.67. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.24. The firm has a market capitalization of $2.32 billion, a P/E ratio of -32.87 and a beta of 1.74.

RXO (NYSE:RXO) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.44 billion. RXO had a negative net margin of 1.25% and a positive return on equity of 0.88%. The business’s revenue for the quarter was up 34.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.05 earnings per share. As a group, sell-side analysts predict that Rxo Inc will post 0.31 EPS for the current fiscal year.

RXO Company Profile

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.